We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Normunity Stock

Invest in or calculate the value of your shares in Normunity or other pre-IPO companies through EquityZen's platform.

Get Started

Normunity Stock (NORU)

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

About Normunity Stock

Founded

2021

Headquarters

West Haven, CT, US

Industries

Content and Publishing, Messaging and Telecommunications, Advertising

Normunity is a biotechnology company creating a new class of precision immuno-oncology medicines, called immune normalizers, that target novel mechanisms that free the body’s normal immunity against cancer. Based on an ongoing, interactive academic-biotech alliance with the lab of Dr. Lieping Chen at Yale School of Medicine, Normunity is targeting newly-discovered mechanisms of immune disruption in cancer based on proprietary discovery platforms that elucidate the complex interactions between human cancer and the immune system. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer. Normunity is located in Boston, Massachusetts and West Haven, Connecticut.

Normunity Management

Leadership team at Normunity

Board Member

Paulina Hill

Chief Operating Officer and Chief Business Officer

Olga Granaturova

Locked Features

Join now and verify your accreditation status to gain access to:

  • Normunity Current Valuation
  • Normunity Stock Price
  • Normunity Management
  • Available deals in Normunity and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Normunity Cap Table and Funding History by Share Class and Liquidity Preferences
    • Normunity Revenue and Financials
    • Normunity Highlights
    • Normunity Business Model
    • Normunity Risk Factors
  • Normunity Research Report from SACRA Research
Join Now

Trading Normunity Stock

How to invest in Normunity stock?

Accredited investors can buy pre-IPO stock in companies like Normunity through EquityZen funds. These investments are made available by existing Normunity shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Normunity stock?

Shareholders can sell their Normunity stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."